NCT02922556

Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Posit Science Corporation · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Accepted

Summary

To assess the efficacy of a mobile-device-deployed cognitive emotional treatment for depression (Moodify) versus an active control treatment (commercially available computer games).

Detailed description

The study will involve a randomized, controlled, double-blind trial to assess the efficacy of a mobile-device-deployed cognitive emotional treatment for depression (Moodify) versus an active control treatment (commercially available computer games). Moodify is comprised of a novel continuous performance task (CPT) to improve cognitive slowing and lethargy often present in cases of major depressive disorder. This training method is based on an existing, validated cognitive training paradigm (tonic and phasic attention training, TAPAT1; WIRB Study No. 1126399). Moodify will also employ two additional cognitive training modules previously validated in this and other clinical populations.

Conditions

• Major Depressive Disorder

Interventions

Type	Name	Description
OTHER	Computerized Plasticity-Based Adaptive Cognitive Training
OTHER	Commercially available computerized training

Timeline

• Start date: 2015-09-01
• Primary completion: 2019-06-21
• Completion: 2019-06-21
• First posted: 2016-10-04
• Last updated: 2019-06-25

Locations

1 site across 1 country: United States